The
global Biotechnology Market is expected to reach USD
727.1 billion by 2025, according to a new report by Grand View Research, Inc.
The emergence of certain key themes in the biotechnology market is expected to
drive growth in this industry to a lucrative extent.
These
key themes include regenerative medicine and genetics in diagnostics. Presence
of a plethora of companies focusing on the development of regenerative
therapies is anticipated to drive sector growth through to 2025. Technological
advancements pertaining to the penetration of artificial intelligence in this
industry is expected to fuel progress with potential avenues. The companies are
engaged in unleashing machine learning in order to understand individual cancer
cases, while recommending clinical trials.
Supportive
government (and its allied agencies) policies related to synthetic biology is a
major growth impacting driver in this sector. Developed economies such as UK
and the U.S. are critically monitoring and funding synthetic biology R&D
initiatives. For example, in 2010, a six months’ review of synthetic biology
headed by a panel of expert scientists was enforced by the U.S. President and
subsequently conducted a hearing of the Energy and Commerce Committee
exclusively concerning synthetic biology.
To request a sample copy or view summary of this report,
click the link below:
http://www.grandviewresearch.com/industry-analysis/biotechnology-market
http://www.grandviewresearch.com/industry-analysis/biotechnology-market
Further key findings from the report suggest:
- Owing to
technological advancements and widespread application of this field in
various aspects of healthcare, the health segment is expected to exhibit
strong progress in the forecast period
- Continuous
introduction of new biotechnological products to cater to healthcare
entities that are involved in diagnosis, prognosis and biopharmaceutical
development is estimated to propel the market
- Decreasing
costs and rise in number of services in this segment are expected to drive
segment with lucrative avenues
- North
American pharmaceutical and biotech companies have experienced great
success in the recent years resulting in larger share
- Introduction
of technologically advanced products and presence of various biotechnology
based programs such as the UC Davis Biotechnology Program, the University
of California Biotechnology Research and Education Program are attributive
to drive the growth of sector in the coming years
- Asia Pacific
market is anticipated to grow at the most lucrative pace due to changing
health care infrastructure in this region which drives the demand for
these products
- Strong
governmental support and recruitment of highly trained Chinese scientists
with the support of their administration has made it possible for China to
speedily build up capacity in area of regenerative medicine
- Key players
operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG,
Sanofi Aventis, and Lonza
Grand
View Research has segmented the biotechnology market on the basis of
technology, application, and region:
Biotechnology Technology Outlook (Revenue, USD
Million; 2014 - 2025)
- DNA
Sequencing
- Nanobiotechnology
- Tissue
engineering and Regeneration
- Fermentation
- Cell Based
Assay
- PCR
Technology
- Chromatography
Market
- Others
Biotechnology Application Outlook (Revenue, USD Million;
2014 - 2025)
- Health
- Food &
Agriculture
- Natural
Resources & Environment
- Industrial
Processing
- Bioinformatics
- Others
Biotechnology Regional Outlook (Revenue, USD Million;
2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle East
and Africa (MEA)
- South Africa
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment